Baqsimi Euroopan unioni - liettua - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - gliukagono - cukrinis diabetas - kasos hormonai, hormonų glycogenolytic - baqsimi fluorouracilu ir folino sunkių blogiau suvokia hipoglikemijos keliamus pavojus suaugusiems, paaugliams ir vaikams nuo 4 metų ir vyresni, su cukriniu diabetu.

Retsevmo Euroopan unioni - liettua - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antinavikiniai vaistai - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Mounjaro Euroopan unioni - liettua - EMA (European Medicines Agency)

mounjaro

eli lilly nederland b.v. - tirzepatide - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 ir 5.

Rayvow Euroopan unioni - liettua - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - migrenos sutrikimai - analgetikai - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Omvoh Euroopan unioni - liettua - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolitas, spazmas - imunosupresantai - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Angeliq Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

angeliq

lex ano, uab - estradiolis/drospirenonas - plėvele dengtos tabletės - 1 mg/2 mg - drospirenone and estrogen

Angeliq Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

angeliq

limedika, uab - estradiolis/drospirenonas - plėvele dengtos tabletės - 1 mg/2 mg - drospirenone and estrogen

Angeliq Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

angeliq

limedika, uab - estradiolis/drospirenonas - plėvele dengtos tabletės - 1 mg/2 mg - drospirenone and estrogen

Angeliq Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

angeliq

lex ano, uab - estradiolis/drospirenonas - plėvele dengtos tabletės - 1 mg/2 mg - drospirenone and estrogen

Torzelip Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

torzelip

ideal trade links, uab - ezetimibas/atorvastatinas - tabletės - 10 mg/10 mg - atorvastatin and ezetimibe